BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim DH, Cheon JH. Pathogenesis of Inflammatory Bowel Disease and Recent Advances in Biologic Therapies. Immune Netw 2017;17:25-40. [PMID: 28261018 DOI: 10.4110/in.2017.17.1.25] [Cited by in Crossref: 129] [Cited by in F6Publishing: 123] [Article Influence: 25.8] [Reference Citation Analysis]
Number Citing Articles
1 Nascimento RPD, Machado APDF, Galvez J, Cazarin CBB, Maróstica Junior MR. Ulcerative colitis: Gut microbiota, immunopathogenesis and application of natural products in animal models. Life Sci 2020;258:118129. [PMID: 32717271 DOI: 10.1016/j.lfs.2020.118129] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
2 Sapci I, Gorgun E. Minimally Invasive Surgery in Complex Crohn's Disease. Clin Colon Rectal Surg 2019;32:300-4. [PMID: 31275077 DOI: 10.1055/s-0039-1683922] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Lovatt J, Gascoyne-Binzi D, Hussey T, Garside M, McGill F, Selinger CP. Screening for TB in Hospitalised Patients with Inflammatory Bowel Disease before Anti-TNF Therapy: Is QuantiFERON® Gold Testing Useful? J Clin Med 2021;10:1816. [PMID: 33919426 DOI: 10.3390/jcm10091816] [Reference Citation Analysis]
4 Park MY, Yoon YS, Lee JL, Park SH, Ye BD, Yang SK, Yu CS. Comparative perianal fistula closure rates following autologous adipose tissue-derived stem cell transplantation or treatment with anti-tumor necrosis factor agents after seton placement in patients with Crohn's disease: a retrospective observational study. Stem Cell Res Ther 2021;12:401. [PMID: 34256838 DOI: 10.1186/s13287-021-02484-6] [Reference Citation Analysis]
5 Vu V, Muthuramalingam K, Singh V, Hyun C, Kim YM, Unno T, Cho M. Effects of β-glucan, probiotics, and synbiotics on obesity-associated colitis and hepatic manifestations in C57BL/6J mice. Eur J Nutr 2021. [PMID: 34561722 DOI: 10.1007/s00394-021-02668-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Su HJ, Chiu YT, Chiu CT, Lin YC, Wang CY, Hsieh JY, Wei SC. Inflammatory bowel disease and its treatment in 2018: Global and Taiwanese status updates. J Formos Med Assoc. 2019;118:1083-1092. [PMID: 30054112 DOI: 10.1016/j.jfma.2018.07.005] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 6.8] [Reference Citation Analysis]
7 Larabi A, Barnich N, Nguyen HTT. Emerging Role of Exosomes in Diagnosis and Treatment of Infectious and Inflammatory Bowel Diseases. Cells. 2020;9. [PMID: 32365813 DOI: 10.3390/cells9051111] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
8 Deng L, Wang S, Zhang R, Huang J, Lin Y, Liu X, Lu Z, Li M, Tan W. Protective effects of (R)-enantiomers but not (S)-enantiomers of β2-adrenergic receptor agonists against acute colitis: The role of β2AR. Int Immunopharmacol 2022;110:108997. [PMID: 35767902 DOI: 10.1016/j.intimp.2022.108997] [Reference Citation Analysis]
9 Dard L, Blanchard W, Hubert C, Lacombe D, Rossignol R. Mitochondrial functions and rare diseases. Mol Aspects Med 2020;71:100842. [PMID: 32029308 DOI: 10.1016/j.mam.2019.100842] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
10 Leite Dantas R, Bettenworth D, Varga G, Weinhage T, Wami HT, Dobrindt U, Roth J, Vogl T, Ludwig S, Wixler V. Spontaneous onset of TNFα-triggered colonic inflammation depends on functional T lymphocytes, S100A8/A9 alarmins, and MHC H-2 haplotype. J Pathol 2020;251:388-99. [PMID: 32449525 DOI: 10.1002/path.5473] [Reference Citation Analysis]
11 Bernardes C, Russo P, Carvalho D, Saiote J, Ramos J. Safe use of infliximab for the treatment of severe perianal Crohn's disease after diagnosis and treatment of lymphoma. Clin J Gastroenterol 2018;11:48-52. [PMID: 29168104 DOI: 10.1007/s12328-017-0802-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
12 Geng Y, Yue Y, Guan Q, Ren Y, Guo L, Fan Y, Lu ZM, Shi JS, Xu ZH. Cereal Vinegar Sediment Alleviates Spontaneous Ulcerative Colitis in Il-10 Deficient Mice. Mol Nutr Food Res 2021;:e2001227. [PMID: 34699119 DOI: 10.1002/mnfr.202001227] [Reference Citation Analysis]
13 Singh V, Gowda CP, Singh V, Ganapathy AS, Karamchandani DM, Eshelman MA, Yochum GS, Nighot P, Spiegelman VS. The mRNA-binding protein IGF2BP1 maintains intestinal barrier function by up-regulating occludin expression. J Biol Chem 2020;295:8602-12. [PMID: 32385106 DOI: 10.1074/jbc.AC120.013646] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
14 Díaz-díaz C, Wilson R, Vazquez-rivera E, Mezrich J, Lee C, Kennedy G, Bradfield C. The Aryl Hydrocarbon Receptor as a Regulator of Barrier Physiology. Comprehensive Toxicology. Elsevier; 2018. pp. 132-47. [DOI: 10.1016/b978-0-12-801238-3.64217-4] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Argollo M, Fiorino G, Hindryckx P, Peyrin-biroulet L, Danese S. Novel therapeutic targets for inflammatory bowel disease. Journal of Autoimmunity 2017;85:103-16. [DOI: 10.1016/j.jaut.2017.07.004] [Cited by in Crossref: 59] [Cited by in F6Publishing: 55] [Article Influence: 11.8] [Reference Citation Analysis]
16 Ghoreschi K, Augustin M, Baraliakos X, Krönke G, Schneider M, Schreiber S, Schulze-Koops H, Zeißig S, Thaçi D. TYK2 inhibition and its potential in the treatment of chronic inflammatory immune diseases. J Dtsch Dermatol Ges 2021;19:1409-20. [PMID: 34580985 DOI: 10.1111/ddg.14585] [Reference Citation Analysis]
17 Krueger JG, McInnes IB, Blauvelt A. Tyrosine kinase 2 and Janus kinase‒signal transducer and activator of transcription signaling and inhibition in plaque psoriasis. J Am Acad Dermatol 2021:S0190-9622(21)02017-X. [PMID: 34224773 DOI: 10.1016/j.jaad.2021.06.869] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
18 Mousavifar L, Roy R. Recent development in the design of small 'drug-like' and nanoscale glycomimetics against Escherichia coli infections. Drug Discov Today 2021:S1359-6446(21)00110-0. [PMID: 33667654 DOI: 10.1016/j.drudis.2021.02.025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Zhang C, Ju J, Wu X, Yang J, Yang Q, Liu C, Chen L, Sun X. Tripterygium wilfordii Polyglycoside Ameliorated TNBS-Induced Colitis in Rats via Regulating Th17/Treg Balance in Intestinal Mucosa. J Inflamm Res 2021;14:1243-55. [PMID: 33833546 DOI: 10.2147/JIR.S293961] [Reference Citation Analysis]
20 Núñez-Sánchez MA, Colom J, Walsh L, Buttimer C, Bolocan AS, Pang R, Gahan CGM, Hill C. Characterizing Phage-Host Interactions in a Simplified Human Intestinal Barrier Model. Microorganisms 2020;8:E1374. [PMID: 32906839 DOI: 10.3390/microorganisms8091374] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Kameli N, Becker HEF, Welbers T, Jonkers DMAE, Penders J, Savelkoul P, Stassen FR. Metagenomic Profiling of Fecal-Derived Bacterial Membrane Vesicles in Crohn's Disease Patients. Cells 2021;10:2795. [PMID: 34685776 DOI: 10.3390/cells10102795] [Reference Citation Analysis]
22 Li J, Zhou H, Fu X, Zhang M, Sun F, Fan H. Dynamic role of macrophage CX3CR1 expression in inflammatory bowel disease. Immunol Lett 2021;232:39-44. [PMID: 33582183 DOI: 10.1016/j.imlet.2021.02.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Ma C, Sedano R, Almradi A, Casteele NV, Parker CE, Guizzetti L, Schaeffer DF, Riddell RH, Pai RK, Battat R, Sands BE, Rosty C, Dubinsky MC, Rieder F, Harpaz N, Abreu MT, Bryant RV, Lauwers GY, Kirsch R, Valasek MA, Crowley E, Sandborn WJ, Feagan BG, Pai RK, Jairath V. An International Consensus to Standardize Integration of Histopathology in Ulcerative Colitis Clinical Trials. Gastroenterology 2021;160:2291-302. [PMID: 33610533 DOI: 10.1053/j.gastro.2021.02.035] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
24 Ghoreschi K, Augustin M, Baraliakos X, Krönke G, Schneider M, Schreiber S, Schulze-Koops H, Zeißig S, Thaçi D. TYK2-Inhibition: Potenzial bei der Behandlung chronisch-entzündlicher Immunerkrankungen. J Dtsch Dermatol Ges 2021;19:1409-20. [PMID: 34661350 DOI: 10.1111/ddg.14585_g] [Reference Citation Analysis]
25 Araruna ME, Serafim C, Alves Júnior E, Hiruma-Lima C, Diniz M, Batista L. Intestinal Anti-Inflammatory Activity of Terpenes in Experimental Models (2010-2020): A Review. Molecules 2020;25:E5430. [PMID: 33233487 DOI: 10.3390/molecules25225430] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Cao H, Liu J, Shen P, Cai J, Han Y, Zhu K, Fu Y, Zhang N, Zhang Z, Cao Y. Protective Effect of Naringin on DSS-Induced Ulcerative Colitis in Mice. J Agric Food Chem. 2018;66:13133-13140. [PMID: 30472831 DOI: 10.1021/acs.jafc.8b03942] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 9.8] [Reference Citation Analysis]
27 Valmiki S, Ahuja V, Puri N, Paul J. miR-125b and miR-223 Contribute to Inflammation by Targeting the Key Molecules of NFκB Pathway. Front Med (Lausanne) 2019;6:313. [PMID: 32039213 DOI: 10.3389/fmed.2019.00313] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
28 Jackson DN, Panopoulos M, Neumann WL, Turner K, Cantarel BL, Thompson-Snipes L, Dassopoulos T, Feagins LA, Souza RF, Mills JC, Blumberg RS, Venuprasad K, Thompson WE, Theiss AL. Mitochondrial dysfunction during loss of prohibitin 1 triggers Paneth cell defects and ileitis. Gut 2020;69:1928-38. [PMID: 32111635 DOI: 10.1136/gutjnl-2019-319523] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 13.0] [Reference Citation Analysis]
29 Almási N, Török S, Valkusz Z, Tajti M, Csonka Á, Murlasits Z, Pósa A, Varga C, Kupai K. Sigma-1 Receptor Engages an Anti-Inflammatory and Antioxidant Feedback Loop Mediated by Peroxiredoxin in Experimental Colitis. Antioxidants (Basel) 2020;9:E1081. [PMID: 33158023 DOI: 10.3390/antiox9111081] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Melsheimer R, Geldhof A, Apaolaza I, Schaible T. Remicade® (infliximab): 20 years of contributions to science and medicine. Biologics 2019;13:139-78. [PMID: 31440029 DOI: 10.2147/BTT.S207246] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
31 Antonioli L, Fornai M, Romano B, Pellegrini C, Blandizzi C. Editorial: IBD Management-Novel Targets and Therapeutic Perspectives. Front Pharmacol 2020;11:448. [PMID: 32372955 DOI: 10.3389/fphar.2020.00448] [Reference Citation Analysis]
32 Piedra-Quintero ZL, Serrano C, Villegas-Sepúlveda N, Maravillas-Montero JL, Romero-Ramírez S, Shibayama M, Medina-Contreras O, Nava P, Santos-Argumedo L. Myosin 1F Regulates M1-Polarization by Stimulating Intercellular Adhesion in Macrophages. Front Immunol 2018;9:3118. [PMID: 30687322 DOI: 10.3389/fimmu.2018.03118] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
33 Rahmaisyah D, Wasityastuti W, Astarini FD, Widasari DI. Protective effects of yacon syrup powder on colonic interleukin-23 and leukocyte infiltration profile in TNBS-induced colitis mouse model. MNM 2022. [DOI: 10.3233/mnm-211506] [Reference Citation Analysis]
34 Duan L, Huang H, Zhao X, Zhou M, Chen S, Wang C, Han Z, Han ZC, Guo Z, Li Z, Cao X. Extracellular vesicles derived from human placental mesenchymal stem cells alleviate experimental colitis in mice by inhibiting inflammation and oxidative stress. Int J Mol Med 2020;46:1551-61. [PMID: 32945344 DOI: 10.3892/ijmm.2020.4679] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
35 Zhang Y, Han D, Yu S, An C, Liu X, Zhong H, Xu Y, Jiang L, Wang Z. Protective Effect of Iridoid Glycosides of the Leaves of Syringa oblata Lindl. on Dextran Sulfate Sodium-Induced Ulcerative Colitis by Inhibition of the TLR2/4/MyD88/NF-κB Signaling Pathway. Biomed Res Int 2020;2020:7650123. [PMID: 32337275 DOI: 10.1155/2020/7650123] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Kostoff RN, Briggs MB, Shores DR. Treatment repurposing for inflammatory bowel disease using literature-related discovery and innovation. World J Gastroenterol 2020; 26(33): 4889-4899 [PMID: 32952337 DOI: 10.3748/wjg.v26.i33.4889] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
37 Kosmidou M, Karavasili NT, Saridi M, Skamnelos A, Kavvadias A, Batistatou A, Gartzonika KG, Tsiara S, Katsanos KH, Christodoulou DK. Clostridium Difficile Infection in Patients Impact Suspected Cytomegalovirus Infection in Patients with Inflammatory Bowel Disease. Mater Sociomed 2020;32:41-5. [PMID: 32410890 DOI: 10.5455/msm.2020.32.41-45] [Reference Citation Analysis]
38 Jung ES, Choi KW, Kim SW, Hübenthal M, Mucha S, Park J, Park Z, Ellinghaus D, Schreiber S, Franke A, Oh WY, Cheon JH. ZNF133 is associated with infliximab responsiveness in patients with inflammatory bowel diseases. J Gastroenterol Hepatol 2019;34:1727-35. [PMID: 30851117 DOI: 10.1111/jgh.14652] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
39 Argollo MC, Kotze PG, Spinelli A, Gomes TN, Danese S. The impact of biologics in surgical outcomes in ulcerative colitis. Best Practice & Research Clinical Gastroenterology 2018;32-33:79-87. [DOI: 10.1016/j.bpg.2018.05.014] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
40 Azimirad M, Krutova M, Balaii H, Kodori M, Shahrokh S, Azizi O, Yadegar A, Aghdaei HA, Zali MR. Coexistence of Clostridioides difficile and Staphylococcus aureus in gut of Iranian outpatients with underlying inflammatory bowel disease. Anaerobe 2020;61:102113. [DOI: 10.1016/j.anaerobe.2019.102113] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
41 Binienda A, Fichna J, Salaga M. Recent advances in inflammatory bowel disease therapy. European Journal of Pharmaceutical Sciences 2020;155:105550. [DOI: 10.1016/j.ejps.2020.105550] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Mirmiran P, Moslehi N, Morshedzadeh N, Shivappa N, Hébert JR, Farsi F, Daryani NE. Does the inflammatory potential of diet affect disease activity in patients with inflammatory bowel disease? Nutr J 2019;18:65. [PMID: 31684946 DOI: 10.1186/s12937-019-0492-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
43 Vasant DH, Ford AC. Functional gastrointestinal disorders in inflammatory bowel disease: Time for a paradigm shift? World J Gastroenterol 2020; 26(26): 3712-3719 [PMID: 32774052 DOI: 10.3748/wjg.v26.i26.3712] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Adjouzem CF, Gilbert A, Mbiantcha M, Yousseu Nana W, Matah Marthe Mba V, Djuichou Nguemnang SF, Tsafack EG, Atsamo AD. Effects of Aqueous and Methanolic Extracts of Stem Bark of Alstonia boonei De Wild. (Apocynaceae) on Dextran Sodium Sulfate-Induced Ulcerative Colitis in Wistar Rats. Evid Based Complement Alternat Med 2020;2020:4918453. [PMID: 32565862 DOI: 10.1155/2020/4918453] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
45 Besednova NN, Zaporozhets TS, Kuznetsova TA, Makarenkova ID, Kryzhanovsky SP, Fedyanina LN, Ermakova SP. Extracts and Marine Algae Polysaccharides in Therapy and Prevention of Inflammatory Diseases of the Intestine. Mar Drugs 2020;18:E289. [PMID: 32486405 DOI: 10.3390/md18060289] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
46 Kochar B, Herfarth HH. Vaccinations in Adult Patients with Inflammatory Bowel Diseases in the West. Inflamm Intest Dis 2018;3:11-5. [PMID: 30505837 DOI: 10.1159/000491752] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
47 Karthikeyan A, Young KN, Moniruzzaman M, Beyene AM, Do K, Kalaiselvi S, Min T. Curcumin and Its Modified Formulations on Inflammatory Bowel Disease (IBD): The Story So Far and Future Outlook. Pharmaceutics 2021;13:484. [PMID: 33918207 DOI: 10.3390/pharmaceutics13040484] [Reference Citation Analysis]
48 Younis N, Zarif R, Mahfouz R. Inflammatory bowel disease: between genetics and microbiota. Mol Biol Rep 2020;47:3053-63. [PMID: 32086718 DOI: 10.1007/s11033-020-05318-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
49 Bodini G, Zanella C, Crespi M, Lo Pumo S, Demarzo MG, Savarino E, Savarino V, Giannini EG. A randomized, 6-wk trial of a low FODMAP diet in patients with inflammatory bowel disease. Nutrition 2019;67-68:110542. [PMID: 31470260 DOI: 10.1016/j.nut.2019.06.023] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
50 Soares IP, Oliveira BAC, Baal SCS, Donatti L, Ingberman M, Beirão BCB, Appel MH, Fernandes LC. Fish oil supplementation enhances colon recovery after experimental colitis. Prostaglandins Leukot Essent Fatty Acids 2020;163:102212. [PMID: 33249348 DOI: 10.1016/j.plefa.2020.102212] [Reference Citation Analysis]
51 Florholmen JR, Johnsen KM, Meyer R, Olsen T, Moe ØK, Tandberg P, Gundersen MD, Kvamme JM, Johnsen K, Løitegård T, Raschpichler G, Vold C, Sørbye SW, Goll R. Discovery and validation of mucosal TNF expression combined with histological score - a biomarker for personalized treatment in ulcerative colitis. BMC Gastroenterol 2020;20:321. [PMID: 33008302 DOI: 10.1186/s12876-020-01447-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
52 Zhang Z, Shen P, Liu J, Gu C, Lu X, Li Y, Cao Y, Liu B, Fu Y, Zhang N. In Vivo Study of the Efficacy of the Essential Oil of Zanthoxylum bungeanum Pericarp in Dextran Sulfate Sodium-Induced Murine Experimental Colitis. J Agric Food Chem 2017;65:3311-9. [PMID: 28368613 DOI: 10.1021/acs.jafc.7b01323] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
53 Nardone OM, Shivaji UN, Ferruzza V, Ghosh S, Iacucci M. Soluble Blood Markers of Mucosal Healing in Inflammatory Bowel Disease: The Future of Noninvasive Monitoring. Inflamm Bowel Dis 2020;26:961-9. [PMID: 31587036 DOI: 10.1093/ibd/izz226] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
54 Fernandes MA, Verstraete SG, Phan TG, Deng X, Stekol E, LaMere B, Lynch SV, Heyman MB, Delwart E. Enteric Virome and Bacterial Microbiota in Children With Ulcerative Colitis and Crohn Disease. J Pediatr Gastroenterol Nutr 2019;68:30-6. [PMID: 30169455 DOI: 10.1097/MPG.0000000000002140] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 20.0] [Reference Citation Analysis]
55 Wu D, Wu K, Zhu Q, Xiao W, Shan Q, Yan Z, Wu J, Deng B, Xue Y, Gong W, Lu G, Ding Y. Formononetin Administration Ameliorates Dextran Sulfate Sodium-Induced Acute Colitis by Inhibiting NLRP3 Inflammasome Signaling Pathway. Mediators Inflamm. 2018;2018:3048532. [PMID: 29507526 DOI: 10.1155/2018/3048532] [Cited by in Crossref: 15] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
56 Bromke MA, Krzystek-Korpacka M. Bile Acid Signaling in Inflammatory Bowel Disease. Int J Mol Sci 2021;22:9096. [PMID: 34445800 DOI: 10.3390/ijms22169096] [Reference Citation Analysis]
57 Zhu Y, Jiang H, Chen Z, Lu B, Li J, Shen X. Genetic association between IL23R rs11209026 and rs10889677 polymorphisms and risk of Crohn’s disease and ulcerative colitis: evidence from 41 studies. Inflamm Res 2020;69:87-103. [DOI: 10.1007/s00011-019-01296-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
58 Danese S, Peyrin-Biroulet L. Selective Tyrosine Kinase 2 Inhibition for Treatment of Inflammatory Bowel Disease: New Hope on the Rise. Inflamm Bowel Dis 2021:izab135. [PMID: 34089259 DOI: 10.1093/ibd/izab135] [Reference Citation Analysis]
59 Kostoff RN, Briggs MB, Kanduc D, Shores DR, Kovatsi L, Vardavas AI, Porter AL. Common contributing factors to COVID-19 and inflammatory bowel disease. Toxicol Rep 2021;8:1616-37. [PMID: 34485092 DOI: 10.1016/j.toxrep.2021.08.007] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Gu D, Nan Q, Miao Y, Yang H, Li M, Ye Y, Miao J. KT2 alleviates ulcerative colitis by reducing Th17 cell differentiation through the miR-302c-5p/STAT3 axis. Eur J Cell Biol 2022;101:151223. [PMID: 35405463 DOI: 10.1016/j.ejcb.2022.151223] [Reference Citation Analysis]
61 Oliveira ALB, Monteiro VVS, Navegantes-Lima KC, Reis JF, Gomes RS, Rodrigues DVS, Gaspar SLF, Monteiro MC. Resveratrol Role in Autoimmune Disease-A Mini-Review. Nutrients 2017;9:E1306. [PMID: 29194364 DOI: 10.3390/nu9121306] [Cited by in Crossref: 59] [Cited by in F6Publishing: 39] [Article Influence: 11.8] [Reference Citation Analysis]
62 Albuquerque RM, Pizzitola MP, Araújo E Silva AC, Dittz D, Freitas KM, Ferreira Ê, Salas CE, Lopes MTP. The Proteolytic Fraction From Vasconcellea cundinamarcensis Latex Displays Anti-Inflammatory Effect in A Mouse Model of Acute TNBS-Induced Colitis. Sci Rep 2020;10:3074. [PMID: 32080277 DOI: 10.1038/s41598-020-59895-3] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
63 Queiro R, Rodríguez-Caminero S, Riestra S, de Francisco R, Pérez-Martínez I, Ballina J. Performance of Two Screening Questionnaires for Inflammatory Arthritis in Patients with Inflammatory Bowel Disease. Biomed Res Int 2018;2018:8618703. [PMID: 29854801 DOI: 10.1155/2018/8618703] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
64 Ren C, Dokter-Fokkens J, Figueroa Lozano S, Zhang Q, de Haan BJ, Zhang H, Faas MM, de Vos P. Fibroblasts Impact Goblet Cell Responses to Lactic Acid Bacteria After Exposure to Inflammatory Cytokines and Mucus Disruptors. Mol Nutr Food Res 2019;63:e1801427. [PMID: 30977971 DOI: 10.1002/mnfr.201801427] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
65 Ronchetti S, Gentili M, Ricci E, Migliorati G, Riccardi C. Glucocorticoid-Induced Leucine Zipper as a Druggable Target in Inflammatory Bowel Diseases. Inflamm Bowel Dis 2020;26:1017-25. [PMID: 31961437 DOI: 10.1093/ibd/izz331] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
66 Kramer NE, Cosgrove VE, Dunlap K, Subramaniapillai M, Mcintyre RS, Suppes T. A clinical model for identifying an inflammatory phenotype in mood disorders. Journal of Psychiatric Research 2019;113:148-58. [DOI: 10.1016/j.jpsychires.2019.02.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
67 Nie P, Li Z, Wang Y, Zhang Y, Zhao M, Luo J, Du S, Deng Z, Chen J, Wang Y, Chen S, Wang L. Gut microbiome interventions in human health and diseases. Med Res Rev 2019;39:2286-313. [PMID: 30994937 DOI: 10.1002/med.21584] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
68 Notararigo S, Martín-Pastor M, Viñuela-Roldán JE, Quiroga A, Dominguez-Munoz JE, Barreiro-de Acosta M. Targeted 1H NMR metabolomics and immunological phenotyping of human fresh blood and serum samples discriminate between healthy individuals and inflammatory bowel disease patients treated with anti-TNF. J Mol Med (Berl) 2021;99:1251-64. [PMID: 34021361 DOI: 10.1007/s00109-021-02094-y] [Reference Citation Analysis]
69 Fragoulis GE, McInnes IB, Siebert S. JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis. Rheumatology (Oxford) 2019;58:i43-54. [PMID: 30806709 DOI: 10.1093/rheumatology/key276] [Cited by in Crossref: 92] [Cited by in F6Publishing: 93] [Article Influence: 46.0] [Reference Citation Analysis]
70 Heidari Z, Daei M, Boozari M, Jamialahmadi T, Sahebkar A. Curcumin supplementation in pediatric patients: A systematic review of current clinical evidence. Phytother Res 2021. [PMID: 34904764 DOI: 10.1002/ptr.7350] [Reference Citation Analysis]
71 Li DF, Chang X, Zhao JL, Chen XM, Xu ZL, Zhang DG, Wu BH, Wang LS, Bai Y, Yao J. Colonic Epithelial PHLPP2 Deficiency Promotes Colonic Epithelial Pyroptosis by Activating the NF-κB Signaling Pathway. Oxid Med Cell Longev 2021;2021:5570731. [PMID: 34394827 DOI: 10.1155/2021/5570731] [Reference Citation Analysis]
72 Patel JI, Kumbhani M, Raval MM. Protective Effect of Nelumbo nucifera Plant on Dextran Sodium Sulfate-Induced Ulcerative Colitis in Rats. Ann Natl Acad Med Sci. [DOI: 10.1055/s-0042-1743133] [Reference Citation Analysis]
73 Folegatti PM, Bellamy D, Roberts R, Powlson J, Edwards NJ, Mair CF, Bowyer G, Poulton I, Mitton CH, Green N, Berrie E, Lawrie AM, Hill AVS, Ewer KJ, Hermon-Taylor J, Gilbert SC. Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine. Vaccines (Basel) 2019;7:E40. [PMID: 31096710 DOI: 10.3390/vaccines7020040] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
74 Akhtar K, Hirschstein Z, Stefanelli A, Iannilli E, Srinivasan A, Barenboim L, Balkaya M, Cunha A, Audil A, Kochman EM, Chua F, Ravi M, Mikkilineni S, Watkins H, O'Connor W Jr, Fan Y, Cotero V, Ashe J, Puleo C, Kao TJ, Shin DS. Non-invasive peripheral focused ultrasound neuromodulation of the celiac plexus ameliorates symptoms in a rat model of inflammatory bowel disease. Exp Physiol 2021;106:1038-60. [PMID: 33512049 DOI: 10.1113/EP088848] [Reference Citation Analysis]
75 Lenti MV, Cococcia S, Ghorayeb J, Di Sabatino A, Selinger CP. Stigmatisation and resilience in inflammatory bowel disease. Intern Emerg Med 2020;15:211-23. [PMID: 31893346 DOI: 10.1007/s11739-019-02268-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
76 Liu F, Yao Y, Lu Z, Zhang Q, Liu C, Zhu C, Lin C. 5-Hydroxy-4-methoxycanthin-6-one alleviates dextran sodium sulfate-induced colitis in rats via regulation of metabolic profiling and suppression of NF-κB/p65 signaling pathway. Phytomedicine 2021;82:153438. [PMID: 33422953 DOI: 10.1016/j.phymed.2020.153438] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
77 Azmy Nabeh O, Ishak Attallah M, El-Sayed El-Gawhary N. The pivotal relation between glucagon-like peptides, NFκB and inflammatory bowel disease. Clin Exp Pharmacol Physiol 2020;47:1641-8. [PMID: 32511781 DOI: 10.1111/1440-1681.13361] [Reference Citation Analysis]
78 Deng L, Guo H, Wang S, Liu X, Lin Y, Zhang R, Tan W, Srejovic I. The Attenuation of Chronic Ulcerative Colitis by (R)-salbutamol in Repeated DSS-Induced Mice. Oxidative Medicine and Cellular Longevity 2022;2022:1-20. [DOI: 10.1155/2022/9318721] [Reference Citation Analysis]
79 Krzystek-Korpacka M, Kempiński R, Bromke MA, Neubauer K. Oxidative Stress Markers in Inflammatory Bowel Diseases: Systematic Review. Diagnostics (Basel) 2020;10:E601. [PMID: 32824619 DOI: 10.3390/diagnostics10080601] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
80 Nemakayala DR, Cash BD. Excluding inflammatory bowel disease in the irritable bowel syndrome patient: how far to go? Curr Opin Gastroenterol 2019;35:58-62. [PMID: 30407259 DOI: 10.1097/MOG.0000000000000493] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
81 Kumar A, Teslova T, Taub E, Miller JD, Lukin DJ. Comorbid Diabetes in Inflammatory Bowel Disease Predicts Adverse Disease-Related Outcomes and Infectious Complications. Dig Dis Sci 2021;66:2005-13. [PMID: 32617771 DOI: 10.1007/s10620-020-06439-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
82 Selinger CP, Carbery I, Al-Asiry J. The role of biologics in the treatment of patients with inflammatory bowel disease. Br J Hosp Med (Lond) 2018;79:686-93. [PMID: 30526103 DOI: 10.12968/hmed.2018.79.12.686] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
83 Serrya MS, El-Sheakh AR, Makled MN. Evaluation of the therapeutic effects of mycophenolate mofetil targeting Nrf-2 and NLRP3 inflammasome in acetic acid induced ulcerative colitis in rats. Life Sci 2021;271:119154. [PMID: 33539910 DOI: 10.1016/j.lfs.2021.119154] [Reference Citation Analysis]
84 Ren TH, Lv MM, An XM, Leung WK, Seto WK. Activation of adenosine A3 receptor inhibits inflammatory cytokine production in colonic mucosa of patients with ulcerative colitis by down-regulating the nuclear factor-kappa B signaling. J Dig Dis 2020;21:38-45. [PMID: 31714673 DOI: 10.1111/1751-2980.12831] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
85 Teruel AH, Gonzalez-Alvarez I, Bermejo M, Merino V, Marcos MD, Sancenon F, Gonzalez-Alvarez M, Martinez-Mañez R. New Insights of Oral Colonic Drug Delivery Systems for Inflammatory Bowel Disease Therapy. Int J Mol Sci 2020;21:E6502. [PMID: 32899548 DOI: 10.3390/ijms21186502] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
86 Kim S, Eun HS, Jo EK. Roles of Autophagy-Related Genes in the Pathogenesis of Inflammatory Bowel Disease. Cells. 2019;8. [PMID: 30669622 DOI: 10.3390/cells8010077] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 9.7] [Reference Citation Analysis]
87 Putri Umizah L, Wasityastuti W, Indah Widasari D, Setyo P. Effects of Yacon on Colonic IFN-γ and Goblet Cells of 2,4,6-Trinitrobenzene Sulfonic Acid-Induced Colitis Mouse Model. Iran Biomed J 2020;24:281-7. [PMID: 32429633 DOI: 10.29252/ibj.24.5.276] [Reference Citation Analysis]
88 Argollo M, Fiorino G, Peyrin-biroulet L, Danese S. Vedolizumab for the treatment of Crohn’s disease. Expert Review of Clinical Immunology 2018;14:179-89. [DOI: 10.1080/1744666x.2018.1438189] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
89 Dong X, Tang S, Liu W, Qi W, Ye L, Yang X, Ge X, Zhou W. Prognostic significance of the Controlling Nutritional Status (CONUT) score in predicting postoperative complications in patients with Crohn's disease. Sci Rep 2020;10:19040. [PMID: 33149221 DOI: 10.1038/s41598-020-76115-0] [Reference Citation Analysis]
90 Mocanu V, Rajaruban S, Dang J, Kung JY, Deehan EC, Madsen KL. Repeated Fecal Microbial Transplantations and Antibiotic Pre-Treatment Are Linked to Improved Clinical Response and Remission in Inflammatory Bowel Disease: A Systematic Review and Pooled Proportion Meta-Analysis. J Clin Med 2021;10:959. [PMID: 33804464 DOI: 10.3390/jcm10050959] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
91 Imawana RA, Smith DR, Goodson ML. The relationship between inflammatory bowel disease and Helicobacter pylori across East Asian, European and Mediterranean countries: a meta-analysis. Ann Gastroenterol 2020;33:485-94. [PMID: 32879595 DOI: 10.20524/aog.2020.0507] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
92 Ganesan K, Quiles JL, Daglia M, Xiao J, Xu B. Dietary phytochemicals modulate intestinal epithelial barrier dysfunction and autoimmune diseases. Food Frontiers 2021;2:357-82. [DOI: 10.1002/fft2.102] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
93 De Conno B, Pesce M, Chiurazzi M, Andreozzi M, Rurgo S, Corpetti C, Seguella L, Del Re A, Palenca I, Esposito G, Sarnelli G. Nutraceuticals and Diet Supplements in Crohn's Disease: A General Overview of the Most Promising Approaches in the Clinic. Foods 2022;11:1044. [PMID: 35407131 DOI: 10.3390/foods11071044] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
94 Kangwan N, Pintha K, Khanaree C, Kongkarnka S, Chewonarin T, Suttajit M. Anti-inflammatory effect of Perilla frutescens seed oil rich in omega-3 fatty acid on dextran sodium sulfate-induced colitis in mice. Res Pharm Sci 2021;16:464-73. [PMID: 34522194 DOI: 10.4103/1735-5362.323913] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
95 D'Antongiovanni V, Pellegrini C, Benvenuti L, Fornai M, Di Salvo C, Natale G, Ryskalin L, Bertani L, Lucarini E, Di Cesare Mannelli L, Ghelardini C, Nemeth ZH, Haskó G, Antonioli L. Anti-inflammatory Effects of Novel P2X4 Receptor Antagonists, NC-2600 and NP-1815-PX, in a Murine Model of Colitis. Inflammation 2022. [PMID: 35338432 DOI: 10.1007/s10753-022-01663-8] [Reference Citation Analysis]
96 Hanić M, Trbojević-Akmačić I, Lauc G. Inflammatory bowel disease - glycomics perspective. Biochim Biophys Acta Gen Subj 2019;1863:1595-601. [PMID: 31276732 DOI: 10.1016/j.bbagen.2019.07.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
97 Walter L, Canup B, Pujada A, Bui TA, Arbasi B, Laroui H, Merlin D, Garg P. Matrix metalloproteinase 9 (MMP9) limits reactive oxygen species (ROS) accumulation and DNA damage in colitis-associated cancer. Cell Death Dis 2020;11:767. [PMID: 32943603 DOI: 10.1038/s41419-020-02959-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
98 Vadstrup K, Bendtsen F. Anti-NKG2D mAb: A New Treatment for Crohn's Disease? Int J Mol Sci 2017;18:E1997. [PMID: 28926962 DOI: 10.3390/ijms18091997] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
99 Salmenkari H, Laitinen A, Forsgård RA, Holappa M, Lindén J, Pasanen L, Korhonen M, Korpela R, Nystedt J. The use of unlicensed bone marrow-derived platelet lysate-expanded mesenchymal stromal cells in colitis: a pre-clinical study. Cytotherapy 2019;21:175-88. [PMID: 30611671 DOI: 10.1016/j.jcyt.2018.11.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
100 Devi K, Singh N, Jaggi AS. Dual role of sirtuin 1 in inflammatory bowel disease. Immunopharmacol Immunotoxicol 2020;42:385-91. [PMID: 32619377 DOI: 10.1080/08923973.2020.1790595] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
101 Sun Q, Arif M, Chi Z, Li G, Liu CG. Macrophages-targeting mannosylated nanoparticles based on inulin for the treatment of inflammatory bowel disease (IBD). Int J Biol Macromol 2021;169:206-15. [PMID: 33340633 DOI: 10.1016/j.ijbiomac.2020.12.094] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
102 M’koma A. The Multifactorial Etiopathogeneses Interplay of Inflammatory Bowel Disease: An Overview. GastrointestDisord 2018;1:75-105. [DOI: 10.3390/gidisord1010007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
103 Xu J, Tang Y, Sheng X, Tian Y, Deng M, Du S, Lv C, Li G, Pan Y, Song Y, Lou P, Luo Y, Li Y, Zhang B, Chen Y, Liu Z, Cong Y, Plikus MV, Meng Q, Zhou Z, Yu Z. Secreted stromal protein ISLR promotes intestinal regeneration by suppressing epithelial Hippo signaling. EMBO J 2020;39:e103255. [PMID: 32128839 DOI: 10.15252/embj.2019103255] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
104 Zhang Z, Shen P, Xie W, Cao H, Liu J, Cao Y, Zhang N. Pingwei San ameliorates dextran sulfate sodium-induced chronic colitis in mice. J Ethnopharmacol 2019;236:91-9. [PMID: 30844487 DOI: 10.1016/j.jep.2019.01.043] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
105 Mukherjee S, Joardar N, Sengupta S, Sinha Babu SP. Gut microbes as future therapeutics in treating inflammatory and infectious diseases: Lessons from recent findings. J Nutr Biochem 2018;61:111-28. [PMID: 30196243 DOI: 10.1016/j.jnutbio.2018.07.010] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 6.5] [Reference Citation Analysis]
106 Pascoal LB, Palma BB, Chaim FHM, de Castro MM, Damázio TA, Franceschini APMF, Milanski M, Velloso LA, Leal RF. New translational and experimental insights into the role of pro-resolving lipid mediators in inflammatory bowel disease. World J Exp Med 2022; 12(1): 1-15 [DOI: 10.5493/wjem.v12.i1.1] [Reference Citation Analysis]
107 Negroni A, Pierdomenico M, Cucchiara S, Stronati L. NOD2 and inflammation: current insights. J Inflamm Res 2018;11:49-60. [PMID: 29483781 DOI: 10.2147/JIR.S137606] [Cited by in Crossref: 47] [Cited by in F6Publishing: 26] [Article Influence: 11.8] [Reference Citation Analysis]
108 Ashammakhi N, Nasiri R, Barros NR, Tebon P, Thakor J, Goudie M, Shamloo A, Martin MG, Khademhosseini A. Gut-on-a-chip: Current progress and future opportunities. Biomaterials 2020;255:120196. [PMID: 32623181 DOI: 10.1016/j.biomaterials.2020.120196] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 14.0] [Reference Citation Analysis]
109 Kong F, Cai Y. Study Insights into Gastrointestinal Cancer through the Gut Microbiota. Biomed Res Int. 2019;2019:8721503. [PMID: 31341907 DOI: 10.1155/2019/8721503] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
110 Jamilloux Y, El Jammal T, Vuitton L, Gerfaud-Valentin M, Kerever S, Sève P. JAK inhibitors for the treatment of autoimmune and inflammatory diseases. Autoimmun Rev 2019;18:102390. [PMID: 31520803 DOI: 10.1016/j.autrev.2019.102390] [Cited by in Crossref: 80] [Cited by in F6Publishing: 73] [Article Influence: 26.7] [Reference Citation Analysis]
111 Wang C, Baer HM, Gaya DR, Nibbs RJB, Milling S. Can molecular stratification improve the treatment of inflammatory bowel disease? Pharmacol Res 2019;148:104442. [PMID: 31491469 DOI: 10.1016/j.phrs.2019.104442] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
112 Ni Y, Liu M, Yu H, Chen Y, Liu Y, Chen S, Ruan J, Da A, Zhang Y, Wang T. Desmethylbellidifolin From Gentianella acuta Ameliorate TNBS-Induced Ulcerative Colitis Through Antispasmodic Effect and Anti-Inflammation. Front Pharmacol 2019;10:1104. [PMID: 31616306 DOI: 10.3389/fphar.2019.01104] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
113 Tian Y, Xu J, Li Y, Zhao R, Du S, Lv C, Wu W, Liu R, Sheng X, Song Y, Bi X, Li G, Li M, Wu X, Lou P, You H, Cui W, Sun J, Shuai J, Ren F, Zhang B, Guo M, Hou X, Wu K, Xue L, Zhang H, Plikus MV, Cong Y, Lengner CJ, Liu Z, Yu Z. MicroRNA-31 Reduces Inflammatory Signaling and Promotes Regeneration in Colon Epithelium, and Delivery of Mimics in Microspheres Reduces Colitis in Mice.Gastroenterology. 2019;156:2281-2296.e6. [PMID: 30779922 DOI: 10.1053/j.gastro.2019.02.023] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 16.3] [Reference Citation Analysis]
114 Jackson DN, Theiss AL. Gut bacteria signaling to mitochondria in intestinal inflammation and cancer. Gut Microbes 2020;11:285-304. [PMID: 30913966 DOI: 10.1080/19490976.2019.1592421] [Cited by in Crossref: 37] [Cited by in F6Publishing: 42] [Article Influence: 12.3] [Reference Citation Analysis]
115 Mousavifar L, Touaibia M, Roy R. Development of Mannopyranoside Therapeutics against Adherent-Invasive Escherichia coli Infections. Acc Chem Res 2018;51:2937-48. [PMID: 30289687 DOI: 10.1021/acs.accounts.8b00397] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
116 Tafazoli V, Taherifard E, Nimrouzi M, Pasalar M. Therapeutic effect of Plantago major on active severe pancolitis: A case report. Advances in Integrative Medicine 2022;9:90-3. [DOI: 10.1016/j.aimed.2021.03.001] [Reference Citation Analysis]
117 Brnic D, Martinovic D, Zivkovic PM, Tokic D, Vilovic M, Rusic D, Tadin Hadjina I, Libers C, Glumac S, Supe-Domic D, Tonkic A, Bozic J. Inactive matrix Gla protein is elevated in patients with inflammatory bowel disease. World J Gastroenterol 2020; 26(32): 4866-4877 [PMID: 32921963 DOI: 10.3748/wjg.v26.i32.4866] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
118 Krawiec P, Pac-Kożuchowska E. Serum interleukin 17A and interleukin 17F in children with inflammatory bowel disease. Sci Rep 2020;10:12617. [PMID: 32724117 DOI: 10.1038/s41598-020-69567-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
119 Wu Z, Zeng H, Zhang L, Pu Y, Li S, Yuan Y, Zhang T, Wang B. Patchouli Alcohol: a Natural Sesquiterpene Against Both Inflammation and Intestinal Barrier Damage of Ulcerative Colitis. Inflammation 2020;43:1423-35. [PMID: 32388657 DOI: 10.1007/s10753-020-01219-8] [Reference Citation Analysis]
120 Van Malderen K, De Winter BY, De Man JG, De Schepper HU, Lamote K. Volatomics in inflammatory bowel disease and irritable bowel syndrome. EBioMedicine 2020;54:102725. [PMID: 32330874 DOI: 10.1016/j.ebiom.2020.102725] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
121 Ma J, Yin G, Lu Z, Xie P, Zhou H, Liu J, Yu L. Casticin prevents DSS induced ulcerative colitis in mice through inhibitions of NF-κB pathway and ROS signaling: Casticin prevents UC through inhibitions of NF-kB and ROS signaling. Phytotherapy Research 2018;32:1770-83. [DOI: 10.1002/ptr.6108] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
122 Hundhausen C, Schneckmann R, Ostendorf Y, Rimpler J, von Glinski A, Kohlmorgen C, Pasch N, Rolauer L, von Ameln F, Eckermann O, Altschmied J, Ale-Agha N, Haendeler J, Flögel U, Fischer JW, Grandoch M. Endothelial hyaluronan synthase 3 aggravates acute colitis in an experimental model of inflammatory bowel disease. Matrix Biol 2021;102:20-36. [PMID: 34464693 DOI: 10.1016/j.matbio.2021.08.001] [Reference Citation Analysis]
123 Tuzim K, Korolczuk A. An update on extra-oral bitter taste receptors. J Transl Med 2021;19:440. [PMID: 34674725 DOI: 10.1186/s12967-021-03067-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
124 Michetti F, D'ambrosi N, Toesca A, Puglisi MA, Serrano A, Marchese E, Corvino V, Geloso MC. The S100B story: from biomarker to active factor in neural injury. J Neurochem 2019;148:168-87. [DOI: 10.1111/jnc.14574] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 14.8] [Reference Citation Analysis]
125 Hu Y, Ye Z, Wu M, She Y, Li L, Xu Y, Qin K, Hu Z, Yang M, Lu F, Ye Q. The Communication Between Intestinal Microbiota and Ulcerative Colitis: An Exploration of Pathogenesis, Animal Models, and Potential Therapeutic Strategies. Front Med (Lausanne) 2021;8:766126. [PMID: 34966755 DOI: 10.3389/fmed.2021.766126] [Reference Citation Analysis]
126 McLean MR, Lu LL, Kent SJ, Chung AW. An Inflammatory Story: Antibodies in Tuberculosis Comorbidities. Front Immunol 2019;10:2846. [PMID: 31921122 DOI: 10.3389/fimmu.2019.02846] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
127 Sigala-Robles R, Santiago-López L, Hernández-Mendoza A, Vallejo-Cordoba B, Mata-Haro V, Wall-Medrano A, González-Córdova AF. Peptides, Exopolysaccharides, and Short-Chain Fatty Acids from Fermented Milk and Perspectives on Inflammatory Bowel Diseases. Dig Dis Sci 2022. [PMID: 35133532 DOI: 10.1007/s10620-022-07382-2] [Reference Citation Analysis]
128 Caviglia GP, Rosso C, Stalla F, Rizzo M, Massano A, Abate ML, Olivero A, Armandi A, Vanni E, Younes R, Fagoonee S, Pellicano R, Astegiano M, Saracco GM, Bugianesi E, Ribaldone DG. On-Treatment Decrease of Serum Interleukin-6 as a Predictor of Clinical Response to Biologic Therapy in Patients with Inflammatory Bowel Diseases. J Clin Med 2020;9:E800. [PMID: 32183476 DOI: 10.3390/jcm9030800] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
129 Machado FDF, Formiga RO, Lima GRM, de Jesus NZT, Alves Júnior EB, Marinho AF, Tavares JF, Santos FA, Viana AFSC, Araújo AA, de Araújo Júnior RF, Pellizzon CH, Batista LM. Hyptis suaveolens (L.) Poit protects colon from TNBS-induced inflammation via immunomodulatory, antioxidant and anti-proliferative mechanisms. J Ethnopharmacol 2021;265:113153. [PMID: 32702379 DOI: 10.1016/j.jep.2020.113153] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
130 Darch KM, Holland TL, Spelman LJ. Secukinumab-Induced Inflammatory Bowel Disease in a Patient Treated for Chronic Plaque Psoriasis and Psoriatic Arthritis: A Case Report and Review of the Role of Novel Biologic Agents Targeting the p19 Subunit of IL-23. Case Rep Med 2020;2020:9404505. [PMID: 32774388 DOI: 10.1155/2020/9404505] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
131 Kang DW, Dong SH, Kim SH, Kim YI, Park DC, Yeo SG. Expression of endoplasmic reticulum stress-related mRNA in otitis media with effusion. Int J Pediatr Otorhinolaryngol 2019;121:109-13. [PMID: 30878556 DOI: 10.1016/j.ijporl.2019.03.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
132 Mahdavi Sharif P, Jabbari P, Razi S, Keshavarz-fathi M, Rezaei N. Importance of TNF-alpha and its alterations in the development of cancers. Cytokine 2020;130:155066. [DOI: 10.1016/j.cyto.2020.155066] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
133 Finamore A, Peluso I, Cauli O. Salivary Stress/Immunological Markers in Crohn's Disease and Ulcerative Colitis. Int J Mol Sci 2020;21:E8562. [PMID: 33202858 DOI: 10.3390/ijms21228562] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
134 Takač B, Mihaljević S, Glavaš-Obrovac L, Kibel A, Suver-Stević M, Canecki-Varžić S, Samardžija M, Rajkovac I, Kovač D, Štefanić M. INTERACTIONS AMONG INTERLEUKIN-6, C-REACTIVE PROTEIN AND INTERLEUKIN-6 (-174) G/C POLYMORPHISM IN THE PATHOGENESIS OF CROHN'S DISEASE AND ULCERATIVE COLITIS. Acta Clin Croat 2020;59:67-80. [PMID: 32724277 DOI: 10.20471/acc.2020.59.01.09] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
135 Lucafò M, Pugnetti L, Bramuzzo M, Curci D, Di Silvestre A, Marcuzzi A, Bergamo A, Martelossi S, Villanacci V, Bozzola A, Cadei M, De Iudicibus S, Decorti G, Stocco G. Long Non-Coding RNA GAS5 and Intestinal MMP2 and MMP9 Expression: A Translational Study in Pediatric Patients with IBD. Int J Mol Sci 2019;20:E5280. [PMID: 31652976 DOI: 10.3390/ijms20215280] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
136 Uwagbale E, Adeniran OG, Adeniran OA, Onukogu I, Agbroko S, Sonpal N. In-Hospital Outcomes of Inflammatory Bowel Diseases in Patients With Diabetes Mellitus: A Propensity Score Matching Analysis. Cureus 2021;13:e16566. [PMID: 34430168 DOI: 10.7759/cureus.16566] [Reference Citation Analysis]
137 Verma P, Srivastava A, Srikanth CV, Bajaj A. Nanoparticle-mediated gene therapy strategies for mitigating inflammatory bowel disease. Biomater Sci 2021;9:1481-502. [PMID: 33404019 DOI: 10.1039/d0bm01359e] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
138 Shen P, Zhang Z, Zhu K, Cao H, Liu J, Lu X, Li Y, Jing Y, Yuan X, Fu Y, Cao Y, Zhang N. Evodiamine prevents dextran sulfate sodium-induced murine experimental colitis via the regulation of NF-κB and NLRP3 inflammasome. Biomed Pharmacother 2019;110:786-95. [PMID: 30554117 DOI: 10.1016/j.biopha.2018.12.033] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 8.8] [Reference Citation Analysis]
139 Selinger C, Carbonell J, Kane J, Omer M, Ford AC. Acceptability of a 'treat to target' approach in inflammatory bowel disease to patients in clinical remission. Frontline Gastroenterol 2021;12:30-8. [PMID: 33493249 DOI: 10.1136/flgastro-2019-101366] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
140 de Santana Souza MT, Teixeira DF, de Oliveira JP, Oliveira AS, Quintans-Júnior LJ, Correa CB, Camargo EA. Protective effect of carvacrol on acetic acid-induced colitis. Biomed Pharmacother 2017;96:313-9. [PMID: 29017143 DOI: 10.1016/j.biopha.2017.10.017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
141 Baldelli V, Scaldaferri F, Putignani L, Del Chierico F. The Role of Enterobacteriaceae in Gut Microbiota Dysbiosis in Inflammatory Bowel Diseases. Microorganisms 2021;9:697. [PMID: 33801755 DOI: 10.3390/microorganisms9040697] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
142 Giang J, Lan X, Crichton M, Marx W, Marshall S. Efficacy and safety of biophenol-rich nutraceuticals in adults with inflammatory gastrointestinal diseases or irritable bowel syndrome: A systematic literature review and meta-analysis. Nutr Diet 2021. [PMID: 33960587 DOI: 10.1111/1747-0080.12672] [Reference Citation Analysis]
143 Rengasamy KR, Khan H, Gowrishankar S, Lagoa RJ, Mahomoodally FM, Khan Z, Suroowan S, Tewari D, Zengin G, Hassan ST, Pandian SK. The role of flavonoids in autoimmune diseases: Therapeutic updates. Pharmacology & Therapeutics 2019;194:107-31. [DOI: 10.1016/j.pharmthera.2018.09.009] [Cited by in Crossref: 52] [Cited by in F6Publishing: 41] [Article Influence: 17.3] [Reference Citation Analysis]
144 Alquraishi M, Puckett DL, Alani DS, Humidat AS, Frankel VD, Donohoe DR, Whelan J, Bettaieb A. Pyruvate kinase M2: A simple molecule with complex functions. Free Radic Biol Med 2019;143:176-92. [PMID: 31401304 DOI: 10.1016/j.freeradbiomed.2019.08.007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
145 Vaidy K, Winderman R, Rabinowitz SS, Schwarz SM. Treatment of Pyoderma Gangrenosum in Pediatric Inflammatory Bowel Disease. JPGN Reports 2020;1:e008. [DOI: 10.1097/pg9.0000000000000008] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
146 Kubiritova Z, Radvanszky J, Gardlik R. Cell-Free Nucleic Acids and their Emerging Role in the Pathogenesis and Clinical Management of Inflammatory Bowel Disease. Int J Mol Sci 2019;20:E3662. [PMID: 31357438 DOI: 10.3390/ijms20153662] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]